A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus in patients with stage II/III triple-negative breast cancer (TNBC): Responses and long-t...

door Jovanović, Bojana, Mayer, Ingrid A., Mayer, Erica L., Abramson, Vandana G., Bardia, Aditya, Sanders, Melinda E., Kuba, M. Gabriela, Estrada, Monica V., Beeler, J. Scott, Shaver, Timothy M., Johnson, Kimberly C., Sanchez, Violeta, Rosenbluth, Jennifer M., Dillon, Patrick M., Forero-Torres, Andres, Chang, Jenny C., Meszoely, Ingrid M., Grau, Ana M., Lehmann, Brian D., Shyr, Yu, Sheng, Quanhu, Chen, Sheau-Chiann, Arteaga, Carlos L., Pietenpol, Jennifer A.
Gepubliceerd in Clin Cancer Res (2017)